	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	9	159	1,791	-	-	-	-	1	-	1	3	3	-	-	-	-
Cost of Operating Revenue	9	159	1,791	-	-	-	-	1	-	1	3	2	-	-	-	-
Gross Profit	0	0	0	-	-	-	-	0	-	0	1	1	-	-	-	-
Gross Margin	0.3	-	-	-	-	-	-	2.2	-	14.5	17.5	20.0	-	-	-	-
Total Operating Expenses	9	159	1,791	0	0	0	0	1	0	1	3	2	0	0	41	41
Operating Profit	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-41	-41
Operating Margin	-0.6	-0.1	-	-	-	-	-	-1.2	-	0.2	4.1	8.8	-	-	-	-
Financing Income/(Expense) - Net	-	0	0	0	0	0	0	-	-	-	-	-2	-	0	0	-1
Profit before Taxes	0	0	0	0	0	0	0	0	0	0	0	-1	0	-1	-56	-57
Income Taxes	0	0	0	-	-	-	-	-	-	0	0	0	-	-	-	-
Profit after Tax	0	0	0	0	0	0	0	0	0	0	0	-1	0	-1	-56	-57
PAT Margin	-0.9	-0.1	-	-	-	-	-	-1.2	-	0.2	3.0	-51.1	-	-	-	-
EPS - Basic - ex Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-0.02	0.00	-0.01	-1.01	-1.03
EPS - Diluted - ex Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	-0.02	0.00	-0.01	-1.01	-1.03
EBIT	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-41	-41
EBITDA	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-41	-41
EBITDA Margin	0.2	-0.1	-	-	-	-	-	-1.2	-	0.2	4.1	8.8	-	-	-	-

Balance Sheet

Abridged

Understanding Balance Sheet

Johnson Pharmacare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	C 2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	C 2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	PRESS
Total Current Assets	16.41	35.57	25.96	3.82	22.11	11.40	4.28	5.17	4.89	5.60	4.18	0.00	0.00	1.36	2.31
Long-Term Investments	24.53	19.42	29.87	54.00	35.30	45.94	54.03	53.13	52.26	52.26	54.18	45.56	45.56	42.29	19.73
Property Plant & Equipment - Net	1.79	0.02	0.02	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	43.00	23.77	34.16	55.72	36.92	47.57	55.66	54.76	53.88	53.88	55.80	59.83	59.83	56.56	19.73
Total Assets	59.41	59.33	60.12	59.54	59.03	58.97	59.94	59.93	58.77	59.48	59.98	59.83	59.83	57.93	22.03
Total Current Liabilities	0.00	0.06	0.93	0.42	0.05	0.06	0.00	0.00	0.00	0.65	1.13	0.98	1.13	1.15	0.19
Long Term Debt	0.61	0.61	0.61	0.61	0.61	0.61	1.69	1.69	0.63	0.69	0.61	1.91	1.95	0.61	21.40
Total Non-Current Liabilities	0.63	0.63	0.63	0.63	0.63	0.63	1.71	1.71	0.63	0.69	0.61	1.91	1.95	0.61	21.40
Total Liabilities	0.63	0.69	1.56	1.05	0.67	0.68	1.72	1.72	0.63	1.34	1.74	2.88	3.08	1.76	21.60
Total Shareholders' Equity	58.78	58.65	58.56	58.49	58.36	58.29	58.23	58.21	58.14	58.14	58.24	56.95	56.75	56.17	0.44
Total Equity	58.78	58.65	58.56	58.49	58.36	58.29	58.23	58.21	58.14	58.14	58.24	56.95	56.75	56.17	0.44
Total Liabilities & Equity	59.41	59.33	60.12	59.54	59.03	58.97	59.94	59.93	58.77	59.48	59.98	59.83	59.83	57.93	22.03

Cash Flow

Abridged

Understanding Cash Flow Statement

Johnson Pharmacare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	R 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	0	0	0	0	0	0	0	0	0	0	0	-1	0	-1	-56
Working Capital - Increase/(Decrease)	-16	1	4	8	-11	11	-1	-1	0	0	5	1	0	-1	-2
Net CF from Operating Activities	-16	1	4	8	-11	11	-1	-1	0	0	5	0	0	-2	-57
Capital Expenditures - Net	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Net CF from Investing Activities	16	-13	-4	-10	11	-11	0	1	1	-	-5	-5,00,570	-	3	58
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-7	-	1	-1	-	-	1	0	-1	0	0	1	0	-1	0
Net Cash Flow from Financing Activities	0	12	1	2	0	-	1	0	-1	0	0	1	0	-1	0
Free Cash Flow to Equity	-23	1	4	8	-11	11	0	-1	-1	0	5	1	0	-3	-58
Free Operating CF net dividend	-16	1	4	-	-11	11	-1	-1	0	0	5	0	0	-2	-57
Free Operating CF	-16	1	4	-	-11	11	-1	-1	0	0	5	0	0	-2	-57

Business Segment Analysis

Johnson Pharmacare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Johnson Pharmacare Ltd.

Regional Segment Analysis

Johnson Pharmacare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Johnson Pharmacare Ltd.

Historical Segment Analysis

Track how Johnson Pharmacare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Johnson Pharmacare Ltd.

Frequently Asked Questions

What is the revenue of Johnson Pharmacare Ltd.?

The latest trailing twelve month revenue of Johnson Pharmacare Ltd. is ₹ 0.00 Cr. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Johnson Pharmacare Ltd.?

The latest trailing twelve month net profit (PAT) of Johnson Pharmacare Ltd. is ₹ -56.78 Cr, with a 3-year earnings CAGR of -205.14%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Johnson Pharmacare Ltd.?

The operating margin of Johnson Pharmacare Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Johnson Pharmacare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Johnson Pharmacare Ltd. is -1.03. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Johnson Pharmacare Ltd.?

The debt-to-equity ratio of Johnson Pharmacare Ltd. stands at 49.18. The interest coverage ratio is -157.26x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Johnson Pharmacare Ltd.?

The estimated book value per share of Johnson Pharmacare Ltd. is 0.01 (derived from a P/B ratio of 49.29 and market price of ₹ 0.40), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Johnson Pharmacare Ltd.?

The trailing twelve month operating cash flow of Johnson Pharmacare Ltd. is ₹ -57.46 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Johnson Pharmacare Ltd. report consolidated or standalone financials?

Johnson Pharmacare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.